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reChIP-seq reveals widespread bivalency of
H3K4me3 and H3K27me3 in CD4þ memory
T cells
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The combinatorial action of co-localizing chromatin modifications and regulators determines
chromatin structure and function. However, identifying co-localizing chromatin features in a
high-throughput manner remains a technical challenge. Here we describe a novel reChIP-seq
approach and tailored bioinformatic analysis tool, normR that allows for the sequential
enrichment and detection of co-localizing DNA-associated proteins in an unbiased and
genome-wide manner. We illustrate the utility of the reChIP-seq method and normR by
identifying H3K4me3 or H3K27me3 bivalently modified nucleosomes in primary human
CD4þ memory T cells. We unravel widespread bivalency at hypomethylated CpG-islands
coinciding with inactive promoters of developmental regulators. reChIP-seq additionally
uncovered heterogeneous bivalency in the population, which was undetectable by
intersecting H3K4me3 and H3K27me3 ChIP-seq tracks. Finally, we provide evidence that
bivalency is established and stabilized by an interplay between the genome and epigenome.
Our reChIP-seq approach augments conventional ChIP-seq and is broadly applicable to
unravel combinatorial modes of action.
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E
ukaryotic genomes are packaged into chromatin, whose
basic repeating unit is the nucleosome, consisting of two
copies of each core histone, H2A, H2B, H3 and H4 with
B147 base pairs of DNA1,2. The structure and function of
chromatin, determines cell-type-specific gene expression patterns
and cellular identity, which is in part achieved through post-
translational histone modifications. The true complexity of this
histone language is thought to be delivered through combinatorial
histone modifications3,4.
The co-occurrence of bivalent H3K4me3 and H3K27me3
histone modifications, was discovered in embryonic stem cells
(ESCs)5, at developmental genes leading to the hypothesis that
bivalency maintains a poised state5,6. However, the presence of
bivalent domains in differentiated cells, such as pyramidal
neurons7 and T cells8,9 argues that bivalency serves a more
common function. The concept of H3K4me3 and rH3K27me3
bivalency has been met with criticism for several reasons:
(i) H3K4me3 and H3K27me3 are not usually present on the
same peptide10; (ii) in vitro methylation of H3K27 by polycomb
repressive complex 2, is inhibited by the presence of H3K4me3
(refs 11,12); (iii) vice versa the trimethylation of H3K4 by KMT2
complexes is inhibited by the presence of H3K27me3 (ref. 13);
and (iv) due to a lack of direct experimental evidence of the
co-occurrence of H3K4me3 and H3K27me3.
Currently, intersection of H3K4me3 and H3K27me3 ChIP-seq
tracks is the sole method to detect bivalent domains genome-
wide. However, co-enrichment is not sufficient to establish
whether H3K4me3 and H3K27me3 are indeed present on the
same nucleosome and therefore co-localize. They may be present
at the same loci albeit in different cells and/or alleles. To address
this criticism, reChIP qPCR approaches14–17 have been used to
validate co-localization of H3K4me3 and H3K27me3 (ref. 5).
While instructive, a major caveat of these reChIP experiments is
the inefficient capture of the second co-localizing mark, due to
harsh elution steps after the first ChIP. As a consequence, large
amounts of input chromatin are required to obtain sufficient
DNA for sequencing18. Furthermore, the adverse effect of these
harsh elution steps on chromatin epitopes and thereby on the
second ChIP remains unclear. Consequently, the few genome-
wide reChIP studies that have been conducted, have predo-
minantly utilized tagged transgenes19,20, with one exception
where this approach was applied to endogenous targets21.
Here, we describe a highly versatile and efficient reChIP
followed by sequencing (reChIP-seq) approach that utilizes a
much milder elution of bound chromatin through competition
with specific peptides. This in turn generates a chromatin
template suitable for a sequential precipitation of a second
antigen, allowing for the identification of endogenous co-existing
histone modifications on single nucleosomes genome-wide.
Existing bioinformatic approaches22–26 are not well suited to
call enrichment in (re)ChIPs with low signal-to-noise ratio
because they fail to account for the effect of enrichment
on the overall read statistics (Supplementary Note 1). Therefore
we have developed a novel bioinformatic approach called
normR (Supplementary Software, available also at https://
bioconductor.org/packages/normr), which models reChIP-seq
and control primary ChIP-seq read counts to identify regions
enriched for co-localizing histone modifications.
As a proof of principle, we used reChIP-seq and normR to
generate a genome-wide map of bivalency in primary human
CD4þ central memory T cells (TCMs). We explore these
unprecedented data and show that (i) H3K4me3 and H3K27me3
co-exist on single nucleosomes; (ii) that bivalency occurs at
hypomethylated CpG-rich and inactive transcriptional start sites
(TSSs); (iii) that bivalent targets in TCMs predominantly mark
developmental regulators that largely overlap with bivalent
domains in human ESCs; (iv) that 14% of bivalent TSSs identified
by classical co-enrichment of H3K4me3 and H3K27me3 are not
enriched in reChIP-seq, indicating that they are pseudo bivalent;
(v) that the co-enrichment approach additionally fails to detect
up to 60% of bivalent promoters; and (vi) finally, that bivalency
and/or H3K4me3 is an inherent feature of hypomethylated CpG-
rich sequences, which appears to be stable during development
including in the germline.
Results
The reChIP-seq and normR method. Conventional ChIP-seq
approaches are not designed to discern the co-localization of
distinct proteins or histone modifications on the same DNA
template. Therefore, studies aimed at identifying combinatorial
histone features genome-wide are challenged by the lack of an
appropriate experimental approach.
To alleviate this technical deficit, we have developed a reChIP-
seq method that combines a conventional primary ChIP with a
specific peptide elution. The eluted material is used in a secondary
ChIP and the so-isolated DNA is sequenced (Fig. 1a, see
‘Methods’ section). In brief, the efficiency and nucleosome
specificity of this protocol relies on the following technical
considerations: (i) the cross-linked input chromatin needs to be
sheared to mono-/di-nucleosomal lengths to allow for an efficient
elution (Supplementary Fig. 1); (ii) a defined number of cells
should be used to estimate optimal antibody and peptide
concentrations (Supplementary Fig. 2); (iii) the primary ChIPs
are eluted with complementary peptides providing a specific and
non-denatured template for the secondary ChIP; (iv) the paired-
end sequencing libraries are size selected to enrich for DNA
fragments of mono-nucleosomal length; and (v) bioinformatic
analysis should be restricted to fragments longer than 120 and
shorter than 240 base pairs.
Existing peak callers use the relatively uniformly distributed
chromatin input as a control to delineate regions of enrichment
achieved by conventional ChIP-seq. In reChIP-seq, the control
corresponds to the primary ChIP with a more variable signal
distribution. We developed an algorithm, referred to as normR
(Supplementary Software, available also at https://bioconductor.-
org/packages/normr), which fits a binomial mixture model, where
one component corresponds to the background and the other to
the signal. In this way, normR normalizes reChIP-seq data on the
basis of background regions to estimate enrichment and its
statistical significance (see ‘Methods’ section). It performs
comparable to existing peak calling tools (Supplementary
Tables 1-4) but identifies more enriched regions especially in
(re)ChIP-seq experiments yielding a low signal-to-noise ratio
(Supplementary Note 1, Supplementary Table 1). normR outper-
forms the other tested tools in identifying regions with high log2
(re)ChIP over Input fragment counts (Supplementary Figs 3 and
4). Furthermore, it offers the flexibility to define arbitrary
genomic regions such as TSSs or CpG islands.
To illustrate the utility of the reChIP-seq and normR approach,
we identified bivalently modified nucleosomes in TCMs. To this
end, we performed ChIP-seq for H3K4me3 and H3K27me3,
which served as control for H3K4me3 reChIP-seq from
H3K27me3 primary ChIP and H3K27me3 reChIP-seq from
H3K4me3 primary ChIP, respectively. In addition, H3K4me1,
H3K9me3, H3K27ac and H3K36me3 ChIP-seqs, whole-genome
bisulfite sequencing (WGBS) and RNA-seq were performed using
the same sample.
As a first reference, we examined H3K4me3 and H3K27me3
reChIP-seq enrichment at a classical bivalent locus, HOXD
(Fig. 1b). We found that the TSSs of the HOXD genes showed
strong enrichment in H3K4me3 and H3K27me3 ChIPs and
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reChIPs which was accompanied by hypomethylated CpG-rich
DNA, indicating bivalency. These findings validate the ability of
reChIP-seq and normR to detect and map combinatorial bivalent
histone modifications at the mono-nucleosomal level.
reChIP-seq and normR reveal bivalent TSSs in TCMs. The
identification of genomic targets where two antigens co-occur is
ideally based on two reciprocal reChIP-seq experiments, where
antigen A is precipitated first followed by the precipitation of
antigen B and vice versa. However, partial co-occupancy may also
occur, when only one of the two reciprocal re-ChIPs shows
enrichment over its primary ChIP16. This arises when only a
minor fraction of A containing chromatin also contains B
(denoted as AB). In this case, a primary B-ChIP will efficiently
recover antigen A, which can then be enriched by the secondary
A-ChIP. However, when antigen A is precipitated first only very
few copies will also harbour B, leading to statistically negligible
enrichment by the secondary B-ChIP. In these cases, partial
co-occupancy can still be detected as both reciprocal reChIPs will
exhibit enrichment over a chromatin input control.
Considering all possible combinations, we anticipate eight
different patterns for the normalized ratios of the primary ChIPs
over input, reChIPs over their primary ChIPs and reChIPs over
the input (Fig. 2a). These eight distinct patterns discriminate:
(i) full co-occupancy leading to significant high signals in all
six ratios (that is, primary ChIPs over input, reChIPs over their
respective primary ChIP and reChIPs over input); (ii) partial
co-occupancy, where either antigen A or B are predominantly
enriched mixed with a smaller fraction of AB chromatin; or where
loci are devoid of A and B, except for a small AB fraction. This
later partial co-occupancy class was excluded from consideration,
due to the uncertainty of whether it reflects low co-occupancy or
a technical/computational artifact representing the false discovery
rate of our approach (3 TSS out of 72,480; o1%); and (iii) no
co-occupancy, where no enrichment is observed for both reChIPs
and enrichment is observed in the primary ChIPs for A-only,
B-only, A and B (pseudo co-occupancy) or no primary ChIP
enrichment.
We examined H3K4me3, H3K27me3, reH3K4me3 and
reH3K27me3 enrichments over controls at 73,043 TSS for
protein-coding transcripts (GENCODE v19). After removing
TSSs with no signal in the Input or in any of the eight (re)ChIP
experiments, 72,480 TSSs remained. The counts in these TSSs
served as input for normR to call enrichment of the (re)ChIPs
over the respective controls. We performed all the analyses using
q value thresholds of 0.001, 0.01 and 0.1, corresponding to 0.1%,
1% and 10% false discovery rate (FDR). Over this wide range of q
value thresholds, the class assignments remain largely
stable (Supplementary Fig. 5). Here, we show the results at a
FDR of 1%, all results can be recapitulated at a FDR of 0.1%
(Supplementary Fig. 6) and 10% (Supplementary Fig. 7). On
grouping TSSs by their modification pattern outlined above, we
obtained eight classes, where we discarded the low co-occupancy
class as it contained only 3 out of the 72,480 TSSs (Fig. 2b and
Supplementary Data 1).
The first class (black; N¼ 5,539 or 8%) shows enrichment in all
six ratios indicating full co-occupancy and thus is referred to as
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Figure 1 | The reChIP-seq method. (a) Experimental design. Black, purple, red and grey circles denote chromatin containing A and B antigens, only A
antigens, only B antigens, or neither A nor B antigens, respectively. (b) ChIP- and reChIP-seq at the human HOXD locus. The colours of the boxes in the TSS
state track indicate the co-occupancy patterns as described in Fig. 2.
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Figure 2 | reChIP-seq and normR analysis reveals bivalent promoters in primary human CD4þ central memory T cells. (a) Anticipated outcomes after
analysis. (X)/(Y), where X denotes (re)ChIP-seq track (A ChIP, B ChIP, BA reChIP or AB reChIP) normalized by the control Y (I¼ Input, A or B). Yellow,
blue and blue/yellow boxes indicate enrichment, no enrichment or borderline enrichment, respectively. The colours next to the (re)ChIP enrichment
patterns denote: full co-occupancy (black); A antigen partial co-occupancy (beige); B antigen partial co-occupancy (blue); low co-occupancy (yellow);
pseudo co-occupancy (orange); only A antigen (purple); only B antigen (red); or no occupancy (grey). (b) TSS clustered by their enrichment pattern for
H3K4me3, H3K27me3, reChIP H3K4me3 and reChIP H3K27me3 over respective controls resulting in seven classes (see a): black, full bivalent; beige,
H3K4me3 partial bivalent; blue, H3K27me3 partial bivalent; orange, pseudo bivalent; purple, H3K4me3-only; red, H3K27me3-only and grey; unmodified.
Within a class, the TSS are ordered from low (bottom) to high DNA methylation. The gene names on the right denote the gene state of critical regulators of
T Helper subtype differentiation45. Enrichment was calculated by normR (see the ‘Methods’ section) (c) Enrichment/Depletion analysis of the classes in
the top 1,000 most variably expressed genes. Stars indicate statistical significance (***) P valueo0.0001 (Two-sided Fisher’s exact test). (d) Boxplots of
gene expression values of the top 1,000 most variably expressed genes contingent on the class. (e) Enrichment/Depletion analysis of the classified TSSs
on 23 Human chromosomes.
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bivalent. The second class (beige; N¼ 6,210 or 9%) shows
enrichment in the H3K4me3 ChIP, both reChIPs over input and
the H3K4me3 reChIP over the H3K27me3 primary ChIP but no
enrichment for H3K27me3 over input or the H3K27me3 reChIP
over the H3K4me3 primary ChIP. These TSSs are also enriched
for H3K27ac, indicating transcriptional activity. The third class
(blue; N¼ 2,186 or 3%) shows an inverse pattern to the second
class and the absence of H3K27ac indicating that they are
transcriptionally silent. We refer to these classes as H3K4me3 and
H3K27me3 partial bivalent, respectively. The fourth class (orange;
N¼ 882 or 1%) shows enrichment in both primary ChIPs, but no
enrichment in the reChIPs, indicating no co-occupancy and is
denoted as pseudo bivalent. Note that by co-enrichment, class 4
TSSs would have been called bivalent resulting in a false positive
rate ofB14%. The fifth class (purple; N¼ 29,608 or 41%) shows
H3K4me3 and H3K27ac enrichment indicating that they are
active. The sixth class (red; N¼ 13,238 or 18%) only shows
H3K27me3 enrichment indicating that they are inactive. The
majority of these TSSs are DNA hypermethylated, except a small
subclass with low DNA methylation that correspond to high CpG
promoters (Supplementary Fig. 8). Interestingly, this small
divergent subclass shows a similar pattern to the H3K27me3
partial bivalent TSSs, indicating that they are at the border
between the H3K27me3-only and the H3K27me3 partial bivalent
class. Finally, the seventh class (grey; N¼ 14,814 or 20%) shows
no enrichment in the (re)ChIPs and is referred to as unmodified.
This class, however, shows H3K36me3 enrichment, a mark that is
associated with transcriptional elongation27 indicating that many
of these TSSs are internal to an upstream active TSS.
The two partial bivalent and the pseudo bivalent patterns may
reflect heterogeneity in the TCM population. The abundance and
epigenomic state of these subpopulations depend on the
immunological history of both single cell clones as well as of
the donors and, therefore, could be heterogeneous within the total
cell population. We analysed the gene expression variance in an
independent sample of CD4þ TCMs from five donors28. We
calculated the coefficient of variation to obtain a normalized
measure of variability, extracted the top 1,000 most variable genes
and determined the number of genes falling into each of the seven
classes (see the ‘Methods’ section).
Bivalent, H3K4me3-partial bivalent and pseudo bivalent genes
are over-represented in these genes, H3K27me3 partial bivalent
and H3K27me3-only genes are depleted and H3K4me3-only and
unmodified are as frequent as expected by chance (Fig. 2c). This
assignment remains largely unaffected by different choices of the
top K most variable genes (Supplementary Fig. 9). The high
variability in H3K4me3 partial and pseudo bivalent genes is
consistent with the idea that these arise due to heterogeneity on
the cellular or allelic level. The low variability of H3K27me3-only
and H3K27me3 partial bivalent genes is also expected as they are
stably repressed by Polycomb and heterogeneity in the latter is
between two repressed states. However, the high variability in
bivalent genes is unexpected. To investigate the reason for this, we
analysed the gene expression levels for these top 1,000 genes
contingent on the promoter class. The bivalent genes are lower
expressed than H3K4me3 partial and pseudo bivalent genes
(Fig. 2d) indicating that the high gene expression variation in the
bivalent genes may be due to gene expression noise rather than
sample heterogeneity, whereas H3K4me3 partial bivalent and
pseudo bivalent gene expression variation can be explained by
subpopulation heterogeneity.
Another source of heterogeneity may be allele-specific expres-
sion. Consistently, pseudo bivalent TSSs accumulate on the X
chromosome (Fig. 2e). Given that the TCMs have been isolated
from female donors, H3K4me3 and H3K27me3 are likely present
on the active and inactive X, respectively.
These findings indicate that a surprising large number (B20%)
of the 72,480 human TSSs are either partial or full bivalent
in TCMs. Furthermore, while the statistical inference of
co-occupancy by intersection of independent ChIPs is astonish-
ingly specific (false positive rateB14%), it is not very sensitive, as
it missedB60% of co-occupied regions (partial bivalent regions),
due to the fact that either H3K4me3 or H3K27me3 ChIP showed
no statistical significant enrichment. Only the reChIP approach
achieved a sufficient sensitivity in detecting these signatures,
which indicates that technical and/or statistical problems may
preclude the detection of bivalency from the intersection of
conventional ChIPs.
Characterization of genes driven by bivalent promoters. Biva-
lency in ESCs predominantly marks so-called high CpG content
promoters (HCPs) of developmental regulators6. Similarly, in
TCMs, almost all bivalent and H3K4me3 partial bivalent and the
vast majority of H3K27me3 partial bivalent TSSs are HCPs
(Fig. 3a), and are associated with developmental functions
(Fig. 3b, top). H3K4me3 partial bivalent genes in TCMs are
also associated with metabolic functions as are H3K4me3-only
genes, which are additionally associated with immune system
functions. Thus, in TCMs bivalency targets are developmental
regulators as in ESCs but do not preferentially involve regulators
of the different T helper cell subtypes (Supplementary Table 5).
Furthermore, bivalent CpG-rich domains are known to be
hypomethylated in ESCs. We examined DNA methylation levels
across the seven TSS classes to check whether this holds true in
TCMs (Fig. 3c). We found that unmodified and H3K27me3-only
TSSs were highly DNA methylated, whereas H3K4me3-only and
all bivalent states are DNA hypomethylated. Furthermore, full
bivalent TSSs were significantly less DNA methylated than
pseudo bivalent. H3K4me3 partial bivalent TSSs yielded
significantly lower DNA methylation levels than H3K4me3-only
ones (Fig. 3c and Supplementary Fig. 10)—an observation that is
also true for H3K27me3 partial bivalent compared with
H3K27me3-only. Thus, the bivalent state coincides with DNA
hypomethylation at TSSs in TCMs as in ESCs.
These results suggest a functional overlap between bivalent
genes in TCMs and ESCs and argue against a TCM-specific
function of bivalency. To test this idea, we examined the overlap
between bivalent genes in human ESCs as identified by the
Bivalent Gene Database (BGDB)29 with the TSS states in TCMs.
This comparison revealed that 450% of the bivalent ESC genes
are bivalent (30%), H3K4me3 partial (11%) or H3K27me3 partial
bivalent genes (13%) in TCMs, that is, ESC bivalent genes are
over-represented in these three TCM bivalent classes (Fig. 3d).
Most of the remaining ESC bivalent genes resolve either to
H3K27me3-only (17%) or H3K4me3-only (23%) and only 3%
become unmodified in TCMs. This shows that most bivalent TSSs
in ESCs remain at least partially bivalent in TCMs and
that B40% resolve to either an H3K4me3- or H3K27me3-only
state—a phenomenon that has been observed during ESC
differentiation6. It is interesting to note that TCMs harbour
many more partial and full bivalent TSSs (between 77 and 93%
are TCM-specific), indicating either that they were not detected
before or that the bivalent state was gained during development.
The latter is consistent with observations of Mohn et al. that
bivalency can be gained during development7.
Further evaluation of the associated functional terms revealed
that the genes that remain bivalent, become H3K27me3 partial
bivalent or resolve to H3K27me3-only are associated with
developmental functions. The genes that resolve to H3K4me3-
only are depleted in developmental functions (Fig. 3b, bottom),
but interestingly are, like H3K4me3 partial bivalent genes,
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12514 ARTICLE
NATURE COMMUNICATIONS | 7:12514 | DOI: 10.1038/ncomms12514 | www.nature.com/naturecommunications 5
associated with immune system functions. These findings
demonstrate that bivalency in both ESCs and TCMs targets
developmental genes, whereas those that resolve into the
H3K4me3-only state drive cell-type-specific genes.
Bivalency in ESCs is affiliated with transcriptional repression.
We therefore wanted to explore the effect of bivalency on
transcription in TCMs (see the ‘Methods’ section). We found that
H3K4me3-only and H3K4me3 partial bivalent genes are
transcriptionally active (Fig. 3e) consistent with H3K27ac
enrichment in these classes (Fig. 2b). In contrast, full bivalent,
H3K27me3 partial bivalent, H3K27me3-only and unmodified
genes are associated with no or little transcriptional activity.
Bivalent genes showed a significantly lower gene expression level
than pseudo bivalent genes supporting the idea that the latter are
active (H3K4me3-only) in some cells or alleles and repressed
(H3K27me3-only) in others. A further comparison of H3K4me3-
only with H3K4me3 partial bivalent and H3K27me3-only with
H3K27me3 partial bivalent genes revealed that the expression
levels of partial bivalent TSSs are significantly lower. These results
are confirmed by an independent RNA-seq study measuring gene
expression in CD4þ TCMs of five donors28 (Fig. 3e). Thus,
similar to ESCs, bivalency in TCMs leads to transcriptional
repression.
Together these findings indicate that characteristic features of
the bivalent state in human ESCs, namely transcriptional
repression, CpG-richness, DNA hypomethylation and association
with the TSSs of developmental regulators, are largely maintained
in TCMs. Furthermore, they demonstrate that the full, H3K4me3
partial and H3K27me3 partial bivalent classes show distinct
characteristics, which are different from the pseudo bivalent,
H3K4me3-only and H3K27me3-only classes underlining the
added benefit of reChIP-seq and our analysis.
Sequence characteristics of bivalent promoters. The conserva-
tion of the bivalent state between ESCs and TCMs at hypo-
methylated HCPs suggests that it may be determined by the DNA
sequence. A comparison of GþC and CpG content stratified by
the seven promoter classes revealed that full and partial bivalency
is associated with a high GþC and CpG content, while unmo-
dified and H3K27me3-only coincides with a low GþC and CpG
content (Fig. 4a,b). To account for the high correlation between
GþC and CpG content (Supplementary Fig. 11), we calculated
the odds ratio of observed CpG content over expected CpG
content from the GþC content. The statistical association of
bivalency with CpG remains after accounting for the effect of the
GþC content (Fig. 4c), indicating that a high GþC content and
a high CpG content is characteristic of bivalency.
Next, we turned to CpA/TpG odds, which are negatively
correlated to the CpG odds (Supplementary Fig. 12). CpA and
TpG are the products of deamination of methylated CpGs and
their over-representation indicates germline DNA methylation
and deamination. H3K4me3-only, full bivalent and partial
bivalent promoters show a median odds ratio of B1 (Fig. 4d),
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Figure 3 | Functional characterization of genes driven by bivalent promoters. (a) Distribution of the seven TSS classes in High CpG content promoters
(HCPs). (b) GO-term enrichment of the seven classes for GO:0032502 (developmental process), GO:0008152 (metabolic process) and GO:0002376
(immune system process). Shown are the calculated log2 fold enrichment in the respective terms indicated by the colour (see colour key). Top, for all
genes; bottom for genes annotated to be bivalent by BGDB29. Stars indicate statistical significance: (***) P value o0.0001, (**) P value o0.001 and
(*) P value o0.05 (Two-sided Fisher’s exact test). (c) Boxplots of DNA methylation levels contingent on the seven promoter classes. (***) P value
o2.2e 16 (Wilcoxon signed-rank test). (d) Top, enrichment/depletion analysis of BGDB bivalent genes in the seven classes. Stars indicate statistical
significance as in b; bottom, percentage of TSS in the different classes. Dark bars denote TSS overlapping with the BGDB bivalent genes; fair bars denote the
genomic distribution. (e) Boxplots of gene expression for the different classes. Dark coloured, gene expression measured in the sample used for (re)ChIP;
fair coloured, gene expression average over five independent central memory T-cell samples28.
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indicating no over-representation of CpA/TpG in these TCM TSS
classes and arguing that their DNA hypomethylated state is
present in the germline. In contrast, CpA/TpG are over-
represented in unmodified and H3K27me3-only promoters
(median odds ratio41.2), indicating germline DNA methylation
and deamination. Together, these findings support that DNA
hypomethylation, high CþG and high CpG content is conserved
in the germline and defines essential prerequisites for the
establishment of bivalency in ESCs and TCMs.
Bivalency is the response to unmethylated CpG-rich DNAs. To
disentangle the epigenetic and genetic requirements for bivalency,
we classified 27,537 CpG islands in the human genome defined by
their sequence characteristics30 into the aforementioned
enrichment patterns for H3K4me3, H3K27me3, reH3K4me3
and reH3K27me3 (Supplementary Data 2). Different q value
thresholds led to limited changes in the classification (Supple-
mentary Fig. 13). We performed the analysis using q value
thresholds qo0.001 (Supplementary Fig. 14), qo0.01 (Fig. 5) and
qo0.1 (Supplementary Fig. 15). As only 115 CpG islands were
classified to low co-occupancy and 115 to be pseudo bivalent, we
removed these two classes from further analysis. Bivalent CpG
islands strongly overlapped with the reChIPs and H3K4me3 (full
bivalent: N¼ 1,681 or 6% of CpG islands, H3K4me3 partial
bivalent: N¼ 1,540 or 6% and H3K27me3 partial bivalent:
N¼ 1,149 or 4%). These showed either no or low levels of
DNA methylation. Similarly, B32% of the CpG islands were
H3K4me3-only (N¼ 8,672), which likewise showed either no or
low levels of DNA methylation. The remaining 51% of CpG
islands were H3K27me3-only (N¼ 2,757 or 10%) or unmodified
(N¼ 11,508 or 41%) and showed high DNA methylation levels.
These patterns demonstrate that hypomethylated CpG islands
coincide with H3K4me3 and the bivalent state genome-wide even
when decoupled from promoters. The conservation of these
features together with the fact that bivalent and H3K4me3-
only CpG islands in TCMs show a depletion of CpA/TpG
di-nucleotides (Fig. 5) strongly argues for their germline DNA
hypomethylation and indicates a stabilizing interplay between the
genome and the epigenome.
Discussion
We have developed and applied a reChIP-seq protocol and the
normR algorithm to analyse and dissect modes of H3K4me3 and
H3K27me3 bivalency at the nucleosomal level on a genome-wide
scale. Using this method, we could unambiguously assign various
types of bivalency occurring at developmental promoters in
TCMs. Similar to ESCs, we found that hypomethylated CpG-rich
promoters are either H3K4me3-only and transcriptionally active
or bivalent and transcriptionally repressed. This dual mode
indicates that hypomethylated CpG-rich promoters can switch
between a bivalent off and a H3K4me3 on state (Fig. 6a). On the
contrary, DNA hypermethylated CpG-rich promoters/regions are
either unmodified or show an H3K27me3-only state (Fig. 6b).
Likewise, CpG-poor promoters are predominantly unmodified or
H3K27me3-only, with only a minor fraction carrying H3K4me3
(Fig. 6c).
On the basis of our findings as well as the work of others, we
conclude that the bivalent state is a dual repression control
mechanism, where H3K27me3 represses transcription and
H3K4me3 suppresses DNA methylation (Fig. 6d,e). Unmethy-
lated CpGs recruit H3K4me3 methyltransferases31 and H3K4me3
inhibits DNA methylation by preventing the recruitment of de
novo DNA methyltransferases32–34, which creates a feedback loop
stabilizing the DNA hypomethylated state. In the absence of
activating transcription factors35, these CpG-rich sequences gain
H3K27me3 leading to the bivalent state and transcriptional
repression (Fig. 6d); whether the acquisition of H3K27me3
depends on H3K4me3 or not remains unclear. This state is not
static and the binding of transcriptional activators at these regions
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Figure 4 | Sequence characteristics of bivalent promoters. (a) Boxplots of
the GþC content in percentage, (b) the CpG content in percentage, (c) the
CpG odds, that is, observed CpG count over the expected CpG count and
(d) the CpA/TpG (deamination products of methylated CpGs) odds.
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Figure 5 | Bivalency is the default response to unmethylated CpG-rich DNA sequences. CpG islands clustered by their enrichment pattern for H3K4me3,
H3K27me3, reChIP H3K4me3 and reChIP H3K27me3 over respective controls. Fragment coverage for the tracks indicated above each column (1 to 4) for
each CpG island (rows, sorted by CpG island length)±2,000 base pairs centred around the centre of the CpG island. The fifth column represents DNA
methylation (0 denotes no DNA methylation and 1 denotes full DNA methylation). The last two columns represent the CpG content and the CpGA/TpG
content in percentage.
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promotes H3K27me3 removal and its replacement by H3K27ac
leading to transcriptional activation (Fig. 6e). The DNA
hypomethylated state of H3K4me3-only and bivalent classes
appears to be conserved in the germline, leading us to hypothesize
that the feedback cycle between DNA hypomethylation and
H3K4me3/bivalency is a mechanism to protect against excessive
mutations resulting from deamination in developmental
promoters. Collectively, these mechanisms thereby reflect a
robust interplay between genetic and epigenetic inheritance.
The prerequisite for our analysis was the development of a
reChIP-seq protocol to discern the co-localization of two proteins
at a single-nucleosome resolution and a tailored bioinformatic
analysis. The combination of both facilitates the separation of
true co-localizations from those cases where the co-enrichment of
the two antigens is not due to physical co-localization. Moreover,
it provides a very sensitive tool to discern heterogeneous co-
occupancy, which remained undetected by the co-enrichment of
primary ChIPs. The reChIP-seq approach requires peptide-
derived antibodies or monoclonal antibodies with known epitope,
which may limit its applicability. Peptide elution yields non-
denaturated native chromatin for the secondary ChIP in contrast
to previous procedures that relied on elution by, for example,
dithiothreitol14,17, which denatures the chromatin. As a result,
our approach alleviates the requirement of large amounts of input
chromatin18 but may still not be efficient enough for low
abundance chromatin features. Thus, the proposed reChIP-seq
approach has a broad application range, especially when sample
amounts are limited, but requires antibodies with defined
epitopes and the corresponding peptide to efficiently elute the
captured chromatin.
A specific elution of enriched chromatin from primary ChIPs
by peptide competition is the principal technical requirement for
an efficient reChIP. The elution, however, becomes increasingly
difficult when multiple antigens are present on the precipitated
chromatin template resulting in many interactions that have to be
broken simultaneously. This problem can be diverted by shearing
the chromatin to mono/di-nucleosomal levels, thereby limiting
the antigen–antibody interactions. This reduction becomes
particularly important when analysing broad histone marks such
as H3K27me3, where a series of neighbouring nucleosomes
contain the primary target antigen. However, when this caveat is
taken into consideration and the chromatin is sheared appro-
priately, our reChIP approach functions as demonstrated here for
H3K27me3.
Overall, our results demonstrate that reChIP-seq and the
proposed analysis have a great potential to provide detailed
biological insight into the co-localization of proteins and/or their
modifications and may be instrumental to decode the combina-
torial complexity in histone modification patterns and their
functional consequences.
Methods
Isolation of primary human central memory T cells. Buffy coats from female
donors were obtained from the DRK Blutspendedienst, Berlin, Germany. Use of
buffy coats for scientific purposes in the DEEP project was approved by the ethics
committee of the Charite Universitaetsmedizin Berlin (Ethikkommission,
Ethikausschuss 1 am Campus Charite Mitte) under the application number EA1/
095/13. Informed consent was given by the donors. Peripheral blood mononuclear
cells were separated using a LSM 1077 density gradient (PAA, GE Healthcare).
Remaining erythrocytes were lysed using the Buffer EL (Qiagen). CD4þ T cells
were pre-enriched using anti-CD4 microbeads and the AutoMACS magnetic
separation system (Miltenyi Biotec). MACS-sorted CD4þ T cells were surface
stained using the following directly conjugated antibodies (all purchased from
BioLegend, except CD45RA that was purchased from Beckman Coulter): CD3
(clone: UCHT1), CD4 (OKT4), CD25 (BC96), CD45RA (2H4LDH11LDB9),
CD62L (DREG-56), CD127 (A019D5). The CD4þ central memory T cells were
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Figure 6 | Cross-talk between genome and epigenome. (a–c) The filled circles denote the relative fraction of TSSs in the indicated state. Purple indicates
H3K4me3-only, red H3K27me3-only, black bivalent and grey the unmodified state. Continuous lines indicate possible transitions, while broken lines
indicate a low probability of a transition between the states. (d,e) Possible models promoting either a bivalent (d) or H3K4me3-only state (e) as depicted in
a. H3K4me3X and H3K27me3Y indicate that they reside on two different H3-tails, while H3K4me3XY indicates that H3K4me3 is on both H3-tails of a
nucleosome.
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sorted as outlined in Supplementary Fig. 16a according to the surface marker
combination CD3þCD4þCD25lowCD45RACD62Lþ by FACS (Aria,
BD-Bioscience). Purity of the sorted populations was confirmed by flow cytometry
(Supplementary Fig. 16a). TCMs from three donors were pooled and then used to
perform the bivalency ChIP, RNA-seq and whole-genome bisulfite sequencing
experiments.
The reChIP-seq procedure. The cells were crosslinked in 1% formaldehyde at a
concentration of 1 106 cells per ml for 5min at room temperature under rotation,
followed by quenching in 0.125M glycine for 10min. The crosslinked cells were
then pelleted by centrifugation at 16.9g for 5min at 4 C.
The reChIPs were performed with 4 106 primary CD4þ central memory
T cells per primary ChIP. A total of 4 106 cells were lysed in 133 ml 1% SDS lysis
buffer (100mM NaCl, 50mM Tris-HCl pH 8.1, 5mM EDTA, 0.2% NaN3, 1% SDS
and 3% Triton X) for 10min on ice. The cell lysate was then diluted to 0.33% SDS
(or 400 ml) with ChIP Dilution buffer (50mM Tris-HCl pH 8.6, 100mM NaCl,
5mM EDTA and 0.2% NaN3) and resuspended several times using a syringe. The
cell lysate was then divided into 200ml aliquots, transferred to 1.5ml TPX tubes
(Diagenode C30010010-1000) and sheared on a Bioruptor Plus at high intensity for
3 9 cycles. The sheared chromatin lysate was then centrifuged at 16.9g for 20min
at 4 C to pellet debris.
Four hundred microlitres of chromatin (4 106 cells) was diluted with ChIP
dilution buffer to 1,200ml (0.08% SDS) before the addition of the antibody bead
complexes. Four micrograms of polyclonal antibodies H3K4me3 (Diagenode:
C15410003-50), H3K27Ac (Diagenode: C15410196) or H3K27me3 (Diagenode:
C15410195) was incubated with 20 ml of DiaMag Protein A coated magnetic beads
(Diagenode C03010020-150) for 1 h at 4 C under rotation and then washed several
times with ChIP dilution buffer to remove unbound antibodies before the addition
of chromatin. The chromatin lysate (400 ml) and antibody bead complexes were
then incubated for 24 h under rotation at 4 C. The supernatant was then collected
and re-incubated for 24 h at 4 C under rotation with fresh antibody bead
complexes to ensure maximal epitope depletion from the chromatin lysate. The
beads containing the precipitated chromatin were then washed extensively in ChIP
wash buffers 1–4 (ChIP wash buffer 1: 0.1% SDS, 1% Triton X-100, 2mM EDTA,
20mM Tris-HCl pH 7.5 and 150mM NaCl, ChIP wash buffer 2: 0.1% SDS, 1%
Triton X-100, 2mM EDTA, 20mM Tris-HCl pH7.5 and 500mM NaCl, ChIP wash
buffer 3: 0.25M LiCl, 1% NP40, 1% Na deoxycholate, 1mM EDTA and 10mM
Tris-HCl pH 7.5 and ChIP wash buffer 4: 50mM Tris-HCl pH 7.5 and 10mM
EDTA). The beads were then transferred to a new Eppendorf tubes and H3K4me3
and H3K27me3 containing chromatin was eluted from the beads with either 2 mg
of H3K4me3 peptide (Abcam ab1342) or H3K27me3 peptide (Abcam ab1782),
respectively, in 400 ml of ChIP dilution buffer, supplemented with 0.1% SDS
overnight at 4 C under rotation. A total 20% of the eluted chromatin was then
retained as the primary ChIP. The remaining 80% of the eluted material was then
used for the reChIPs and was added to antibody bead complexes containing 1mg of
H3K4me3 (Diagenode: C15410003-50), H3K27ac (Diagenode: C15410196) or
H3K27me3 (Diagenode: C15410195) and 20 ml of DiaMag Protein A coated
magnetic beads (Diagenode C03010020-150). The H3K4me3 eluted chromatin was
reChIPed for H3K27me3 and the H3K27me3 eluted chromatin was reChIPed for
H3K4me3, for 24 h under rotation at 4 C. The beads containing the precipitated
bivalent chromatin were then washed extensively in ChIP wash buffers 1–4,
transferred to new Eppendorf tubes and de-crosslinked in 100 ml TE buffer pH 9.5
(50mM Tris-HCl pH 9.5 and 10mM EDTA) at 65 C overnight, followed by 1 h of
RNAseA treatment (10 ngml) at 55 C and 3 h Proteinase K treatment (3ml) at
55 C. The DNA was then purified from the solution via phenol chloroform
precipitation overnight, lyophilized by a speed vacuum and resuspended in 11 ml of
nuclease free dH20. The purified DNA was quantified by Quibit and ChIP libraries
were generated using Diagenode MicroPlex library preparation kits (C05010010)
according to the manufacturer’s instructions. The libraries were paired-end
sequenced on an Illumina HiSeq 2500 platform.
ChIP qPCR primer sequences.
P53: Forward: 50-GGGTGGATGTGCAAAGAAGT-30
Reverse: 50-GGGTGTAGATGATGGGGATG-30
P53Int: Forward: 50-CTGTGGGTTTGGTGTGTGAG-30
Reverse: 50-GTTGCAGGTTACAGGGCAAT-30
Rad51: Forward: 50-TCTTCTCGAGCTTCCTCAGC-30
Reverse: 50-AGCGCTCTTGTGGTTTGTTT-30
Sox17: Forward: 50-TTTCATGGTGTGGGCTAAGG-30
Reverse: 50-ACCCAGCATCTTGCTCAACT-30
Ovol1: Forward: 50-CACAGAGCTGTGGTCTCTGG-30
Reverse: 50-AGATTGGGAAGACGTGGATG-30
Wnt4: Forward: 50-GAGTCGTTTGCTCTCGGAAC-30
Reverse: 50-TGGAAGGAGTGTGTTCGTTG-30
P16: Forward: 50-CGACTTCAGGGGTGCCACATTC-30
Reverse: 50-TCTTTCCAGGCAAGGGGACGC-30
RNA-seq. Starting from 2 500 ng totalRNA of RIN 9.6, one-stranded totalRNA
and one-stranded mRNA library were prepared according to the manufacturer’s
instructions (Illumina, San Diego, CA, USA). In brief, ribosomal RNA was depleted
using the RiboZero Gold probes (for totalRNA library) and polyadenylated RNA
was enriched using oligo-dT beads (for mRNA library). After chemical fragmen-
tation of both libraries, first- and second-strand cDNA synthesis was performed,
followed by mono-adenylation of 30 ends and adapter ligation. The final library was
PCR amplified and QC’ed on a Bioanalyzer. Both the libraries were sequenced for
2 101 nt on an Illumina HiSeq 2000, yielding about 100 million paired-end reads
for each library.
Whole-genome bisulfite sequencing. To achieve even sequencing coverage
across the genome, two types of sequencing libraries were prepared for WGBS.
For the first type of WGBS library, 100 ng of genomic DNA were used with the
TruSeq methylation kit (Illumina) according to the manufacturer’s protocol.
For the second type, we used the protocol from the TruSeq DNA PCR-Free
Library Preparation Kit (Illumina) with some modifications: In a first step, 2 mg of
DNA were sheared to fragment sizes of 300–500 bp using a Bioruptor NGS device
(Diagenode, Lie`ge, Belgium). Sheared fragments were purified with Ampure beads
XP (Beckman Coulter, Brea, CA, USA) using a two-step procedure and then
subjected to end-repair, A-tailing and NGS-adaptor ligation as described in the
manufaturer’s protocol. Ligations were bisulfite converted using EZ DNA
methylation Gold kit (Zymo, Irvine, CA, USA) and then PCR amplified in six
independent reactions, each consisting of 7 ml of sample, 5 ml of 10x Hot Star Taq
buffer (Qiagen, Hilden, Germany), 5 ml of dNTPs (2.5mM each; Thermo Fisher
Scientific, Waltham, MA, USA), 1 ml of 10mM forward primer (50-AATGATA
CGGCGACCACCGAGATCTACAC-30 ; Metabion, Planegg, Germany), 1 ml of
10 mM reverse primer (50-CAAGCAGAAGACGGCATACGAGAT-30; Metabion),
0.5 ml of Hot Star Taq (Qiagen) and 30.5 ml of aqua bidest. After an initial activation
step (15min at 95 C), the reactions were amplified for nine cycles (30 s at 95 C,
30 s at 60 C and 1min at 72 C), followed by a final elongation step (7min at
72 C) and finally hold at 4 C. The reactions were pooled and then purified with
Ampure beads. Libraries were checked on a Bioanalyzer (Agilent Technologies,
Santa Clara, CA, USA).
The first library type was loaded on one lane, the second library type on two
lanes of a paired-end V3 flowcell (Illumina). Sequencing was performed on a
HiSeq2500 generating 2 100 bp paired-end reads. In total, 1,610,652,952 reads
were produced (B40.1 coverage) of which 1,508,942,939 (93.67%) were mapped
using BWA36. For the bisulfite conversion efficiency, we calculated 99.92% using all
HCH-positions and methylation calls were generated with Bis-SNP37.
Mapping of (re)ChIP-seq paired-end reads. Paired-end reads from sequencing
chromatin Input, primary ChIP and reChIP libraries were mapped to the human
genome version hs37d5 with cnybwa version 0.6.2, which is a hardware re-
implementation of bwa36 version 0.6.2. Mapping was separately performed for the
mates on convey machines:
cnybwa-0.6.2 aln –t 12 –q 20 hs37d5-reference.fa \
sample_R1.fastq.gz 4 sample_R1.sai
cnybwa-0.6.2 aln –t 12 –q 20 hs37d5-reference.fa \
sample_R2.fastq.gz 4 sample_R2.sai
where sample corresponds to the chromatin Input, primary ChIP and reChIP
sample and R1 corresponds to the first and R2 to the second mate.
The resulting single-end *.sai files were paired:
bwa sampe -P -a 1000 -T -t 8 -r readgroupinformation \
hs37d5-reference.fa sample_R1.sai sample_R2.sai \
sample_R1.fastq.gz sample_R2.fastq.gz 4 sample_Sampe_
output
allowing for a maximal insert size of 1,000 base pairs ( a 1,000). The
readgroupinformation is initialized in the script as
‘@RG\tID:$ID\tSM:$SM\tLB:$LB\tPL:ILLUMINA’, where $ID is composed of
run and lane (for example, run130917_SN535_0184_B_D22FWACXX_51_Hf01_
BlCM_Ct_reH3K27me3_ B_1_GCCAAT_L006), $SM the sampletype (for
example, replicate1-reH3K27me3_51_Hf01_BlCM_Ct), and $LB the library (for
example, sample_replicate1-reH3K27me3_51_Hf01_BlCM_Ct).
The resulting sample_Sampe_output was piped into samtools38 version 0.1.19
to convert SAM to BAM and sort by coordinate:
cat sample_Sampe_output | \
samtools view -uSbh - | \
samtools sort -o - 4 sample.bam
Duplicates were marked using Picard tools version 1.125:
java -Xmx50G -jar picard.jar MarkDuplicates
I¼sample.bam \
OUTPUT¼{sample.GALv1.date.bam} \
VALIDATION_STRINGENCY¼SILENT \
REMOVE_DUPLICATES¼FALSE \
ASSUME_SORTED¼TRUE \
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CREATE_INDEX¼TRUE \
MAX_RECORDS_IN_RAM¼12500000 \
METRICS_FILE¼{sample.PicardMarkDupmetrics.
date.txt}
Mapping of RNA-seq paired-end reads. The RNA-seq paired-end reads were
mapped using tophat39 version 2.0.11:
tophat -p 8 --library-type fr-firststrand \
--b2-very-sensitive hs37d5.bowtie2-reference \
sample_R1.fastq.gz sample_R2.fastq.gz
We downloaded RNA-seq data for CD4þ central memory T cells
using accession numbers ERS403433, ERS403431 ERS403284, ERS403403
and ERS403407 (ref. 28). We mapped the reads using STAR40 (version
2.5.1b_modified):
STAR --runmode alignReads \
--genomeDr hs37d5 \
--readFilesCommand zcat \
--outSAMtype BAM SortedByCoordinate \
--readFilesIn ERR_ID_1.fastq.gz ERR_ID_2.fastq.gz
Whole-genome bisulfite sequencing (WGBS). The WGBS paired-end reads
were first trimmed by the default adaptor using SeqPrep version 0.4:
SeqPrep AGATCGGAAGAGCGGTTCAG \
-f {sample_R1.fastq.gz} \
-r {sample_R2.fastq.gz} \
-1 {sample.trimmed.R1.fastq} \
-2 {sample.trimmed.R2.fastq}
The trimmed reads were in silico bisulfite converted using methylCtools version
0.9.2:
methylCtools fqconv sample.trimmed.R1.fastq \
sample_R1.conv.fastq
methylCtools fqconv sample.trimmed.R2.fastq \
sample_R2.conv.fastq
These served as input to cnybwa version 0.6.2
cnybwa-0.6.2 aln –t 12 –q 20 hs37d5_PhiX_Lambda.fa \
sample_R1.conv.fastq 4 sample_R1.sai
cnybwa-0.6.2 aln –t 12 –q 20 hs37d5_PhiX_Lambda.fa \
sample_R2.conv.fastq 4 sample_R2.sai
where hs37d5_PhiX_lambda.fa corresponds to the hs37d5 genome sequence
plus the PhiX lambda genome (control for bisulfite conversion). The resulting
single-end *.sai files were paired:
bwa sampe -t 8 -T -s -P -n 0 -N 0 -r readgroupinformation \
hs37d5-PhiX_Lambda.fa sample_R1.sai
sample_R2.sai \
sample_R1.conv.fastq sample_R2.conv.fastq 4
sample_Sampe_output
The readgroupinformation is explained above (reChIP-seq). The resulting
sample_Sampe_output served as input to the reconversion step of methylCtools:
methylCtools bconv \
--metrics {samples.reconversion.metrics} \
sample_Sampe_output \
methylCtools_reconverted.bam
The resulting methylCtools.reconverted.bam was sorted by coordinate using
samtools:
samtools view -Sbu methylCtools_reconverted.bam | \
samtools sort -o - sorted_lane_bamfile
Duplicates were marked using Picard tools version 1.61:
java -Xmx50G picard-1.61.jar MarkDuplicates I¼{sorted_
lane_bamfile*} \
OUTPUT¼{samplesID.bwa.date.bam} \
TMP_DIR¼{TMP_DIR} \
VALIDATION_STRINGENCY¼SILENT \
REMOVE_DUPLICATES¼FALSE \
ASSUME_SORTED¼TRUE \
CREATE_INDEX¼TRUE \
MAX_RECORDS_IN_RAM¼12500000 \
METRICS_FILE¼{samplesID.PicardMarkDupmetrics.
date.txt}
normR normalization and enrichment calling. ChIP as well as reChIP aims at
enriching chromatin fragments that contains a certain antigen or combination of
antigens. The identity of these chromatin fragments is determined by sequencing
and after mapping to the appropriate genome they are assigned a genomic location.
The accumulation of reads from a (re)ChIP library at certain genomic regions is
then viewed as a proxy for the presence of a certain antigen and/or combination of
antigens. Statistically, the mere accumulation of (re)ChIP reads is, however, not
sufficient for this conclusion, but has to be compared with an appropriate control,
that is, we are interested in the enrichment of (re)ChIP reads over the control.
To quantify enrichment, we developed the normR computational framework.
normR fits a binomial mixture model, where the mixture components correspond
to background B and enrichment E. Given the counts of reads in genomic bins for
the control and the (re)ChIP, we maximize the likelihood:
L ¼
Y
i
ri þ si
si
 
pB yBð Þsi 1 yBð Þri þ 1 pBð Þ yEð Þsi 1 yEð Þri½  ð1Þ
where ri denotes the number of reads in the control, si in the (re)ChIP for bin i, pB
the mixture proportion for the background, yB the proportion of reads from the
(re)ChIP in the background, and yE in enrichment given a total number of reads
for a bin riþ si.
The parameters pB, yB and yE are found by Expectation-Maximization, where
we use the posterior probability that bin i is generated by the background
(enrichment) model:
p Xi ¼ Bð Þ ¼ p
t
BðytBÞsi ð1 ytBÞri
ptBðytBÞsi ð1 ytBÞri þð1 ptBÞðytEÞsi ð1 ytEÞri
ð2Þ
at the values of the parameters ptB, y
t
B andy
t
E at iteration t to re-estimate them:
ptþ 1B ¼
PN
i¼1 p Xi ¼ Bð Þ
N
ð3Þ
where N corresponds to the total number of bins; and
ytþ 1B ¼
PN
i¼1 p Xi ¼ Bð ÞsiPN
i¼1 p Xi ¼ Bð Þ ri þ sið Þ
ð4Þ
ytþ 1E ¼
PN
i¼1 1 p Xi ¼ Bð Þð ÞsiPN
i¼1 1 p Xi ¼ Bð Þð Þ ri þ sið Þ
ð5Þ
until convergence, that is, the likelihood does not change anymore (er0.001).
Expectation-Maximization converges to a local maximum—to increase the chance
to find the global maximum, the EM is started with initial values for yB and yE set
close to y ¼
P
i
siP
i
ri þ si .
Every bin i is tested for significance against the background component.
Resulting P values are filtered using the T method41 (P value threshold 0.0001) and
transformed to q values42. normR is available for download as Supplementary
Software and at https://bioconductor.org/packages/normr.
normR normalized and regularized log enrichment. On the basis of the normR
normalization, a normalized and regularized log enrichment can be calculated. To
account for noise generated by low counts, we adjusted the counts by adding
pseudo counts for control and (re)ChIP, respectively. These pseudo counts were
taken to be the average read counts in the background component:
ar ¼
PN
i¼1 p Xi ¼ Bð ÞriPN
i¼1 p Xi ¼ Bð Þ
ð6Þ
as ¼
PN
i¼1 p Xi ¼ Bð ÞsiPN
i¼1 p Xi ¼ Bð Þ
ð7Þ
Using these pseudo counts, we calculated a regularized log enrichment
ei ¼ ln
si þ as
ri þ ar 
ar
as
 
ð8Þ
where the second term shifts ei* to zero for the background component. To account
for the enrichment achieved by a ChIP experiment, we divide ei* by the log of
average enrichment factor:
fh i ¼ yE
1 yE
1 yB
yB
; ð9Þ
to arrive at a normalized and regularized enrichment ei:
ei ¼ e

i
ln fh i ð10Þ
TSS and CpG island classification. The 50-ends of GENCODE version 19 (ref.
43) protein coding transcripts were extracted and ordered by the TSS coordinate,
transcription direction, and the gene name. Transcripts with the same TSS,
transcription direction and gene name were combined and the transcript with the
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highest number of RNA-seq reads in its first exon was chosen as a representative.
This yielded 73,043 TSSs. We counted fragment centres in a window spanning
±750 base pairs from these TSSs for Input, H3K4me1, H3K4me3, H3K9me3,
H3K27ac, H3K27me3, H3K36me3, H3K4me3 reChIP and H3K27me3 reChIP in R
(ref. 44) using the bioconductor package bamsignals (version 1.4 https://
bioconductor.org/packages/bamsignals). For CpG islands, we downloaded the CpG
island annotation from UCSC and counted reads along the complete length of the
CpG island.
library(bamsignals)
# Genomic Ranges object tss or CpG island
gr ¼ tss
count ¼ bamCount(
bampath ¼ bampath,
gr ¼ gr,
mapqual ¼ 20,
paired.end ¼ ‘‘midpoint’’,
tlen.filter ¼ c(120,240),
filteredFlag ¼ 1024
)
The (re)ChIP libraries were normalized against the appropriate control using
normR:
library(normr)
norm ¼ enrichR(
treatment ¼ counts.(re)ChIP,
control ¼ counts.control,
genome ¼ gr
)
We called a TSS or CpG island enriched in a (re)ChIP using a q value threshold
of 0.001, 0.01 and 0.1:
enriched.0.001 ¼ !is.na(getClasses(norm, fdr ¼ 0.001))
enriched.0.01 ¼ !is.na(getClasses(norm, fdr ¼ 0.01))
enriched.0.1 ¼ !is.na(getClasses(norm, fdr ¼ 0.1))
This procedure yields for every TSS or CpG island and for every (re)ChIP
over control a classification, whether they are enriched or not. We used the
enrichment calls for H3K4me3, H3K27me3, H3K4me3 reChIP and H3K27me3
reChIP over input to cluster the TSSs or CpG islands in eight classes: (i) no
enrichment in any (re)ChIP, (ii) only enrichment in H3K27me3, (iii) only
enrichment in H3K4me3, (iv) enrichment in H3K4me3 and H3K27me3 but not in
the two reChIPs, (v) only enrichment in both the reChIPs but no enrichment
in the primary ChIPs, (vi) enrichment in H3K27me3 and both the reChIPs,
(vii) enrichment in H3K4me3 and both the reChIPs and (viii) enrichment in all the
four (re)ChIPs.
RNA-seq analysis. RNA-seq reads were counted for GENCODE version 19
(ref. 43) protein coding transcripts:
library(GenomicFeatures)
chromInfoDF ¼ read.table(‘‘hs37d5.chrom_sizes’’)
chromInfoDF ¼ data.frame(
chrom ¼ chromInfoDF[, 1],
length ¼ chromInfoDF[, 2],
is_circular ¼ chromInfoDF[,1] ¼ ¼ ‘‘MT’’
)
txdb ¼ makeTxDbFromGFF(
file ¼ ‘‘gencode.v19.annotation.gtf’’,
format ¼ ‘‘gtf’’,
dataSource ¼ ‘‘Gencode 19’’,
organism ¼ ‘‘Homo sapiens’’,
chrominfo ¼ chromInfoDF
)
ebg ¼ exonsBy(txdb, by ¼ ‘‘gene’’)
ebg.reduce ¼ reduce(ebg)
The RNA-seq from our sample reads were counted using bamsignals:
library(bamsignals)
gr ¼ unlist(ebg.reduce)
count ¼ bamCount(
bampath ¼ bampath,
gr ¼ gr,
mapqual ¼ 30,
paired.end ¼ ‘‘filter’’,
ss ¼ TRUE
)[2,]
count ¼ tapply(count, names(gr), sum)
In case of the RNA-seq data for the 5 independent CD4þ Central Memory T
cell samples28 we modified the script:
count ¼ bamCount(
bampath ¼ bampath,
gr ¼ gr,
mapqual ¼ 255,
paired.end ¼ ‘‘filter’’
)
count ¼ tapply(count, names(gr), sum)
The resulting counts were normalized using DESeq2:
library(DESeq2)
dds ¼ DESeqDataSetFromMatrix(countData, colData ¼
sampleData, rowRanges ¼ ebg.reduce, design ¼ B lab)
## regularized log normalization by DESeq2
rld ¼ rlog(dds, blind ¼ FALSE)
where we accounted for the different labs.
Finally, we normalized for the counts for the different exon length:
## generate expression matrix
mat.expr ¼ assay(rld)
## normalize by gene length
mat.expr ¼ apply(mat.expr, 2, function(x) x -
log(geneLength, 2) þ mean(log(geneLength, 2)))
Mapping of promoter classes to genes. To map the promoter classes to genes,
we used a decision tree, where we extracted the classes for the different promoters
of each gene:
gene2class ¼ tapply(class, tss$geneID, function(x){
if (‘‘H3K4me3-only’’ %in% x)
return(‘‘H3K4me3-only’’)
if (‘‘H3K4me3-partial’’ %in% x)
return(‘‘H3K4me3-partial’’)
if (‘‘pseudo’’ %in% x)
return(‘‘pseudo’’)
if (‘‘bivalent’’ %in% x)
return(‘‘bivalent’’)
if (‘‘H3K27me3-partial’’ %in% x)
return(‘‘H3K27me3-partial’’)
if (‘‘H3K27me3-only’’ %in% x)
return(‘‘H3K27me3-only’’)
return(‘‘unmodified’’)
})
Coefficient of variation. For each gene, we determined the expression level by
retransforming the length-normalized rlog values for the RNA-seq data for five
independent CD4þ Central Memory T-cell samples28 provided by DESeq2 (see
above) to the original scale. The coefficient of variation was calculated by dividing
the standard deviation by the mean.
GO enrichment analysis. The GO term annotation was downloaded from
Ensembl 74 via the biomaRt package. The enrichment of the terms GO:0032502
(developmental process), GO:0008152 (metabolic process) and GO:0002376
(immune system process) was tested using the Fisher’s exact test with (i) all
Gencode V19 protein-coding genes and (ii) all Gencode V19 protein-coding
genes overlapping genes with bivalent promoters in human ES cells as back-
ground.
Data availability. (re)ChIP, RNA and whole-genome bisulfite sequencing data
that support the findings of this study have been deposited in the ‘European
Genome-Phenome Archive’ with the accession code EGAS00001001568. The
RNA-seq data for human CD4þ central memory T cells referenced in this study
are available in the ‘European Nucleotide Archive’ with the accession codes
ERP004883 (ref. 28).
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